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Summary
Objective: The purpose of this study was to analyze the biochemical changes in the joint fluid, and pain relief resulting from isometric
quadriceps exercise in patients with osteoarthritis of the knee.
Design: Nineteen osteoarthritic knees in 17 patients with joint effusion were included. The patients performed isometric quadriceps exercise
for 3 months. Isometric muscle torque at 30 and 60° flexion, pain as measured using the visual analog scale and biochemical markers in joint
fluid were evaluated before and after the exercise.
Results: Pain score decreased from 3.9 to 2.3 after 12 weeks of exercise (P<0.001). Extension torque at 30 and 60° knee flexion significantly
increased from 4.7 to 6.9 kgm (47% increase, P<0.001) and from 10.8 to 12.6 kgm (17% increase, P<0.005) after 12 weeks of exercise. The
molecular weight of hyaluronan increased from 2.11 to 2.40×106 (P<0.05) and the viscosity of joint fluid increased from 45.8 to 59.8 mPas
after 12 weeks of exercise (P<0.05). Chondroitin 4-, 6-sulfate concentration in joint fluid decreased from 81.9 to 75.5 nmol/ml (P<0.05).
Conclusions: Isometric quadriceps exercise resulted in significant changes in joint fluid biochemical parameters, and these changes, at least
in part, may explain the ameliorative effect of muscle exercise for osteoarthritis of the knee.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved.
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Introduction
Osteoarthritis (OA) of the knee (knee OA) is a common
cause of chronic lower limb disability in the elderly1,2.
Progression of knee OA produces joint effusion, pain,
deformity, decreased range of motion and quadriceps
muscle weakness, which limit activities of daily living.
Although the pathogenesis of knee OA is still uncertain,
several changes in biochemical markers in joint fluid have
been reported3–6.
Normal joint fluid contains high levels of hyaluronan (HA)
synthesized by synovial lining cells, and HA influences joint
lubrication and cartilage metabolism7–10. It has been
reported that HA concentration in joint fluid and its molecu-
lar weight are decreased in knee OA3,4,6. High-molecular-
weight HA (MWHA) has been injected intra-articularly, and
although it is widely recognized to be an effective treatment
option for knee OA11–13, there has recently been an objec-
tion to its efficacy and it is still controversial14. Other
markers of cartilage degradation have also been measured
in joint fluid. Keratan sulfate (KS) levels increased in
various types of acute arthritis, such as gout, pseudogout
and reactive arthritis15, and chondroitin sulfate (CS) levels
increased in the knees subjected to trauma16. Attempts
have been made to predict the prognosis of OA by
monitoring such markers in serum and/or in the joint fluid,
but have not been practically successful17–19.
Quadriceps muscle weakness is usually present in knee
OA patients, although this weakness is not directly related
to the degree of pain20. Muscle exercise therapy has been
a useful treatment option for the majority of knee OA
patients. Although many studies have been published on
the effect of muscle exercise on muscle strength and
functional ability21–24, the mechanism of its effect remains
uncertain. The purpose of this study was to analyze the
changes in biochemical markers in joint fluid caused by
quadriceps exercise in knee OA patients.
Patients and methods
PATIENTS
The study group consisted of 28 OA knees in 20 patients
(six men and 14 women) with joint effusion. All were
outpatients in our hospital and joined this exercise program
with informed consent. All patients had grade 2 or 3 knee
OA according to the Kellgren and Lawrence criteria, based
on weight-bearing radiographs25. The rheumatoid factor
and C-reactive protein were negative and the erythrocyte
sedimentation rate was less than 40 mm/h in all of them.
During the study period, the amount of joint fluid decreased
and could not be aspirated in nine knees in six patients,
who were excluded from the analysis. The remaining 19
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knees in 17 patients (six men and 11 women) were evalu-
ated. Five knees in five patients without any treatment for
12 weeks were evaluated as a control. The average
durations of knee pain were 9.7±13.4 months in the study
group and 13.0±19.6 months in control group (mean±
standard deviation). No steroid or HA intra-articular injec-
tion had been administered for the previous 2 months
before the study, and instructions for quadriceps exercise
had not previously been given. No patients routinely
used any drugs with known potential for altering cartilage
metabolism, such as nonsteroidal anti-inflammatory drugs.
In the study group, the average age was 64.9±6.6 years,
and age ranged from 56 to 75 years. Average height, body
weight and body mass index (BMI) were 157.5±10.6 cm,
61.9±8.4 kg and 25.1±3.5, respectively. In the control
group, the average age, height, body weight and BMI were
64.0±8.7 years, 162.2±9.8 cm, 64.2±7.6 kg and 24.6±4.1,
respectively. There was no significant difference in demo-
graphic data between the two groups. All the knees had
varus OA, with an average femoro-tibial angle of
179.5±3.8°.
EXERCISE PROGRAM
A straight leg raising (SLR) exercise was chosen as an
isometric quadriceps exercise because it could be con-
tinued by elderly patients without difficulty at home. The
patients were instructed to lie on their back with the
affected leg to be kept straight and the opposite knee
flexed. Then, the leg was raised straight, approximately
20 cm off the ground, and maintained for 10 s with attention
paid to feeling quadriceps muscle contraction. This
exercise was repeated 10 times for both legs (Fig. 1) and
patients were instructed to exercise 90 times a day. The
number of repetitions was counted and recorded daily in a
form provided to the patients. Every 4 weeks, the patients
were seen in the outpatient clinic, and whether they had
performed the exercise correctly was checked. No special
instructions were given to limit their daily activities.
The values recorded before and after the exercise are
discussed in the following sections.
PAIN
A 10-cm horizontal visual analog scale (VAS) was used
for pain assessment. VAS as a measure of self-reported
pain has high test–retest reliability and validity26. VAS was
recorded at baseline and after 4, 8, and 12 weeks of
exercise.
CIRCUMFERENCE OF THE THIGH
The circumference of the thigh was measured above
10 cm from the proximal edge of the patella.
MUSCLE STRENGTH
Maximum isometric quadriceps and hamstring forces
were measured at 30 and 60° of knee flexion using a
MYORET RZ-450 (Kawasaki Heavy Industries, Ltd.,
Japan) at baseline and after 4, 8, and 12 weeks of exercise.
Briefly, the patient was positioned in sitting with 90° hip
flexion. The ankle was attached to a support just above the
malleoli. The axis of the dynamometer was positioned at
the center of rotation of the affected knee. Maximum
extension and flexion contraction were performed con-
tinuously for 5 s. Two trials in each position were performed
at 1-min intervals after two practice contractions.
ANALYSIS OF JOINT FLUID
Joint fluid was aspirated from the knee at baseline and
after 12 weeks of exercise. The pH of the joint fluid was
immediately measured using a portable analyzer (i-STAT®;
i-stat corp. USA). The remaining sample was centrifuged,
and the supernatant was collected and stored at −80°C for
subsequent analysis. The levels of total protein, albumin,
Fig. 1. SLR exercise. The patients were instructed to tighten the quadriceps of one lower limb, keeping the knee straight with ankle
dorsiflexion to 90°, and to raise the leg about 20 cm off the ground in the lying position with the other knee bent. With 10-s pauses, the
procedure was repeated 10 times.
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chondroitin 4-sulfate (C4S), chondroitin 6-sulfate (C6S),
HA, and the ratio of C6S to C4S (C6S:C4S), and MWHA
and joint fluid viscosity were measured. Total protein was
measured by the Biuret method, albumin by nephelometric
immunoassay, CS by high performance liquid chroma-
tography after chondroitinase ABC digestion, and HA by
sandwich binding protein assay using a Hyaluronate-
Chugai test kit (Chugai Pharmaceutical Co., Tokyo, Japan).
The MWHA was calculated27 from the intrinsic viscosity of
HA in joint fluid, which was measured with a capillary
viscometer. Apparent viscosity of joint fluid was measured
using a rotating viscometer at a shear rate of 40 /s at 37°C.
STATISTICAL ANALYSIS
Wilcoxon signed-rank test was used for comparisons
between values obtained before and after exercise. Time-
course of changes in VAS score and maximum torque were
analyzed by one-way repeated-measures ANOVA and
Bonferroni test. P values less than 0.05 were considered
significant.
Results
Patients performed SLR exercise 65 times a day on
average (mean, range: 13–117 times) throughout the
period of investigation. The adequacy of exercise was
confirmed at each examination, and there were no
drop-outs due to complications.
PAIN
VAS score gradually decreased from 3.9±0.6 to 2.3±0.7
(mean±S.E.) after 12 weeks (Fig. 2). The decrease in VAS
score reached significance after 8 weeks of exercise.
Among the patients, the VAS score of one patient
worsened and those of three patients remained un-
changed. There was no significant correlation between the
amount of exercise and VAS score.
CIRCUMFERENCE OF THE THIGH
The circumference of the thigh did not change before and
after exercise (from 43.2±0.6 to 42.9±0.5 cm).
MUSCLE STRENGTH
Knee extension torque at 30 and 60° flexion significantly
increased from 4.7±0.5 to 6.9±0.6 kgm and from 10.8±0.7
to 12.6±0.8 kgm (mean±S.E., 147%, P<0.001 and 117%,
P<0.005, respectively), respectively, after 12 weeks of
exercise. Similar to pain score, the effect on muscle
strength reached significance after 8 weeks. The knee
flexion torque at 30 and 60° flexion changed from 5.5±0.4
to 5.3±0.5 kgm (96%) and from 4.1±0.3 to 4.6±
0.4 kgm (112%), respectively, but these differences were
not significant (Fig. 3).
ANALYSIS OF JOINT FLUID
The results of measurement are summarized in Table I.
The amount of joint fluid significantly decreased from
10.7±1.7 to 6.8±2.0 ml after 12 weeks of exercise
(mean±S.E., P<0.05). pH changed from 7.363±0.008 to
7.385±0.007 (P<0.05). Total protein level in joint fluid
slightly decreased from 2.74±0.17 to 2.66±0.16, but this
difference was not significant. Albumin level decreased
from 1.80±0.08 to 1.66±0.06 (P<0.005). Although C6S level
did not change significantly (from 61.9±6.5 to 57.1±
7.5 nmol/ml), C4S level decreased from 20.0±1.4 to 18.3±
1.5 nmol/ml (P<0.05). C4S+C6S level decreased from
81.9±7.7 to 75.5±8.7 nmol/ml (P<0.05). Ratio C6S:C4S did
not change significantly (from 3.04±0.19 to 3.03±0.22). The
MWHA increased from 2.11±0.13×106 to 2.40±0.12×106
(P<0.05), while HA concentration remained unchanged
(from 1.35±0.13 to 1.34±0.12) (Fig. 4). Joint fluid viscosity
increased from 45.8±7.6 to 59.8±8.6 mPas (P<0.05). In
contrast, there were no significant changes between at
baseline and after 12 weeks in the patients without any
treatment. No correlation between these changes in joint
fluid and the amount of exercise was found.
Discussion
The present study showed that isometric quadriceps
exercise was clinically effective after 3 months. Pain relief
was observed within 4 weeks and reached statistical sig-
nificance after 8 weeks. This study also analyzed the
corresponding biochemical changes in joint fluid. There
have been a few previous studies of biochemical and
metabolic change in joint fluid after exercise. Roos et al.
reported no significant changes in either cartilage proteo-
glycan concentration in joint fluid, or the HA or KS levels
in serum after high-intensity weight-bearing exercise in
healthy athletes28. Messier et al. investigated joint fluid also
after dietary and weight training and walking exercise in
obese older adults with knee OA and reported KS level did
not change, but interleukin-1β decreased after 6 months29.
Bautch et al. also failed to demonstrate significant changes
in KS and hydroxyproline level in joint fluid after 12 weeks
of low-intensity walking exercise in knee OA patients30. In
Fig. 2. Changes in VAS score after exercise. A significant decrease
was found as early as after 8 weeks of exercise. Values are
mean±S.E. *P<0.01, **P<0.001 vs pre-exercise by one-way
repeated-measures ANOVA and Bonferroni test.
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this study, however, significant changes in MWHA, joint
fluid viscosity and CS level were observed. To our knowl-
edge, this is the first report demonstrating such changes in
biochemical markers after quadriceps muscle training as
home exercise in knee OA patients.
HA plays various roles in normal and pathologic joints,
e.g., as a lubricating substance10, in cartilage proteoglycan
metabolism8, in suppression of phagocytosis and chemo-
taxis by polymorphonuclear leukocytes31 and in anal-
gesia32. It has been reported that intra-articular HA injec-
tion inhibits cartilage degeneration in experimental OA
joints, and that its inhibitory effect is more potent with the
higher MWHA33–35. This study showed that the MWHA in
joint fluid increased from 2.11 to 2.40×106 (P<0.05) after
exercise and became closer to that reported for fluid in
normal joints (2.70×106) measured by the same method as
used in the present study36. The higher molecular weight
HA was shown to have higher viscoelasticity and, thus, was
advantageous in view of the joint lubrication37,38. This
study has demonstrated that joint fluid viscosity increased
from 45.8 to 59.8 mPas (P<0.05) after exercise. Thus, it is
reasonable to assume that higher molecular weight HA and
consequently higher viscoelasticity contributed to the pain
relief through effects on joint lubrication.
KS and CS are the major glycosaminoglycans attached
to a core protein of cartilage proteoglycan. More than 90%
of the CS isomer in adult articular cartilage is C6S39, while
C4S is the predominant isomer found in other adult joint
tissues, such as meniscus, ligament, and synovial capsule.
The ratio C6S:C4S in OA patients is lower than in normal
individuals and patients with trauma and higher than in
rheumatoid arthritis patients5. Therefore, these joint fluid
parameters reflect alterations in cartilage metabolism. In
our study, C4S level in joint fluid significantly decreased
from 19.4 to 18.3 nmol/ml (P<0.05) and total concentra-
tions of C4S and C6S decreased from 81.9 to 75.5 nmol/ml
(P<0.05). This decrease in CS level may indicate inhibition
of degradation of the articular cartilage and intra-articular
components after exercise therapy.
The present study revealed a slight but significant
increase in pH and decrease in albumin concentration in
joint fluid after exercise. The pH has been reported to
influence lubrication of countersurfaces in artificial joints.
The variation in pH in periprosthetic fluids, which consist of
Fig. 3. Changes in maximum extension torque and flexion torque after exercise. Extension torque at 30 and 60° of knee flexion was
significantly increased after exercise. Flexion torque at 30 and 60° of knee flexion was not significantly changed by exercise. Values are
mean±S.E. *P<0.05, **P<0.001, †P<0.01, ††P<0.001 vs pre-exercise by one-way repeated-measures ANOVA and Bonferroni test.
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HA solution with γ-globulin, affected the friction coefficient
of countersurfaces between ultra-high-molecular-weight
polyethylene and stainless steel40. However, the changes
in pH in the present study are within the normal range41,
and further study is needed to determine whether these
subtle changes influenced lubrication conditions. The
reduction of albumin was probably due to decreased
inflammatory reaction, since its level in joint fluid is
determined by the permeability of synovial membrane.
A ‘reflex inhibition’ mechanism has been recently advo-
cated as an important cause of quadriceps weakness in
knee OA patients in addition to disuse atrophy19,42. The
idea of reflex inhibition was that various proprioceptive
receptors are present in ligaments, tendons, joint capsule,
joint synovium and hairy skin43–47, and these receptors are
stimulated by pain, ligament stretching, capsule pinching
and effusion48–50, leading to neurogenic inhibition of the
quadriceps muscle. The presence of this mechanism in
knee OA patients was confirmed by the finding that they
have quadriceps weakness even in the asymptomatic
stage19,51. Our results showed that 3-month exercise
resulted in a significant increase in quadriceps strength of
up to 147% without an increase in thigh circumference.
This finding indicated that relief of reflex inhibition played
an important role for increase in muscle strength (Fig. 5). It
has been reported that aspiration of joint effusion produces
increase in quadriceps strength52,53. According to another
finding, the increase was only seen in acute cases, but not
in chronic effusion54. In this study, despite the presence of
considerable effusion (65% of baseline level) after 3-month
exercise, significant muscle strengthening was observed.
This indicated that relief of reflex inhibition was not fully
explained by the decrease in joint effusion.
In this study, pain relief was observed as early as
4 weeks after exercise and became significant after
8 weeks, accompanied by increase in muscle strength.
One fundamental question to be addressed is whether the
changes observed in biochemical markers were the cause
of pain relief or simply the result of joint stabilization by
improvement in muscle strength. It has been widely
believed that stabilization of the knee by muscle strength-
ening is the cause of pain relief in knees with OA. Some
researchers in Japan have claimed that the effect of
quadriceps exercise is due to something other than knee
stabilization, based on the observation that pain relief
preceded increase in muscle strength (H. Kurosawa, per-
sonal communication). In fact, a significant effect of joint
movement on HA metabolism has recently been reported
by Pitsillides et al.55. They found that immobilization of the
joint resulted in decrease in HA level in joint fluid and in
synovial cell (type B) uridine diphosphoglucose dehydro-
genase (UDPGD) activity, which is essential for HA synthe-
sis. Thus, it is possible that the increase in MWHA and
other biochemical changes in joint fluid were due to stimu-
lation to synovial cells or intra-articular components by
repeated muscle contraction (Fig. 5). Although metabolism
in the joint is affected by complex regulatory mechanism,
such as circulation, nervous system and humoral factors,
the findings in this study demonstrated that a biomechani-
cal stimulation to the synovium by muscle exercise had
altered physiological condition of synovial cells, which
Table I
Outcome measures for joint fluid before and after exercise*
Exercise group (n19) Control group (n5)
Pre Post Pre Post
volume (ml) 10.7 (9.0)±1.7 6.8 (3.0)±2.0† 20.0 (16.9)±2.6 12.6 (13.8)±3.5
pH 7.363 (7.370)±0.008 7.385 (7.390)±0.007† NA NA
TP (mg/dl) 2.74 (2.71)±0.17 2.66 (2.63)±0.16 3.03 (3.10)±0.15 2.98 (3.27)±0.20
Alubmin (mg/dl) 1.80 (1.88)±0.08 1.66 (1.63)±0.06† 2.22 (2.36)±0.11 2.04 (2.21)±0.13
C4S (nmol/ml) 20.0 (18.3)±1.4 18.3 (16.3)±1.5† 17.0 (17.9)±0.94 17.9 (16.7)±1.3
C6S (nmol/ml) 61.9 (56.8)±6.6 57.1 (48.9)±7.5 51.7 (50.8)±6.6 49.7 (53.1)±3.2
C4S+C6S (nmol/ml) 81.9 (76.7)±7.7 75.5 (65.4)±8.7† 68.7 (69.0)±7.31 67.7 (69.0)±3.83
Ratio C6S:C4S 3.04 (2.92)±0.19 3.03 (2.96)±0.22 3.09 (3.10)±0.29 2.83 (2.51)±0.21
Ha (mg/ml) 1.35 (1.32)±0.13 1.34 (1.29)±0.12 1.24 (1.11)±0.23 1.18 (1.05)±0.20
MWHA††×106 2.11 (2.12)±0.13 2.40 (2.42)±0.12† 2.17 (2.14)±0.09 2.20 (2.15)±0.04
viscosity (mPas) 45.8 (37.4)±7.6 59.8 (47.6)±8.6† 50.4 (56.2)±11.3 60.3 (49.5)±18.1
N.A., not available.
*Values are mean±S.E.
†P<0.05. P determined by Wilcoxon signed-rank test for comparison before and after exercise.
††MWHA, molecular weight of HA.
Fig. 4. Changes in MWHA after isometric quadriceps exercise in all
the 19 knees. The MWHA increased in most of the patients. The
means differ significantly before and after exercise (P<0.05 by
Wilcoxon signed-rank test).
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resulted in the change in MWHA and subsequently led to
the pain relief in knee OA. Further study is needed to
determine as to how these biochemical changes in joint
fluid lead to improvement in clinical symptoms in knee OA.
In conclusion, 8 weeks of isometric quadriceps exercise
for patients with knee OA was very effective in improving
clinical symptoms. In addition to significantly increasing in
quadriceps muscle strength, the exercise had effects on HA
metabolism in arthritic knee joints after 3 months. Such
biochemical changes might be directly responsible for pain
relief in OA patients.
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